Clinical drug development for digestive disorders and diseases, such as inflammatory bowel disease and functional GI disorders, presents a unique set of challenges for developing new and effective treatments.
CROMSOURCE has extensive experience in conducting gastrointestinal studies across the entire drug development spectrum, ranging from the initial studies in Phase I through post-marketing efforts in Phase IV for medicinal products and in medical devices at IDE and non-IDE stages.
Our clinical trial experience includes but is not limited to the following gastrointestinal indications:
- Acute Pancreatitis
- Biliary Duct Stenosis
- Colorectal Conditions
- Crohn’s Disease
- Liver Cirrhosis
- Exocrine pancreatic insufficiency in cystic fibrosis
- Intestinal transit modulation
- Inflammatory Bowel Disease
- Irritable Bowel Disease
- Gastroenteritis Infections
- Pancreatic cancer
- Ulcerative Colitis